reThought Raises $15.5M in Series A Funding
02 Aug, 2021
– Suono Bio, Inc. has raised an $8.5m Series A financing led by Axil Capital and Mizuho Securities Principal Investment, with participation by Taiwania Capital and other investors.
– Suono Bio will utilize the funds to advance its lead programs in inflammatory bowel disease as well as expansion of its pipeline.
– The company leverages technology developed in the laboratory of Institute Professor Robert Langer at the Massachusetts Institute of Technology (MIT) to facilitate rapid, local administration of therapeutics to treat serious diseases.
– The company was founded by Professor Langer, Professor Giovanni Traverso, from the Department of Mechanical Engineering at MIT and a gastroenterologist and biomedical engineer at Brigham and Women’s Hospital, Harvard Medical School, and Dr. Carl Schoellhammer.